This Week in PLOS

A team from Australia, the US, and Singapore describes a crucial role for the host enzyme fibrillarin during infection by henipaviruses such as the Hendra virus or Nipah virus — bat-borne viruses that are studied in level 4 biosafety facilities due to their pathogenicity. As they report in PLOS Pathogens, the researchers used a genome-wide small interfering RNA screen to search for genetic vulnerabilities in human cells infected by henipavirus.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.